On Friday, Shares of ConocoPhillips (NYSE:COP), lost -1.29% to $57.20.
ConocoPhillips, declared an enhance in its quarterly dividend from $0.73 per share to $0.74 per share, payable on Sept. 1, 2015 to stockholders of record at the close of business on July 27, 2015.
“A compelling dividend is a key aspect of our value proposition to shareholders,” commented Ryan Lance, chairman and CEO. “While this enhance is more modest than in previous years, we believe it is appropriate given the lower commodity price environment.”
ConocoPhillips explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas, and natural gas liquids worldwide.
Shares of Merge Healthcare Inc. (NASDAQ:MRGE), inclined 1.63% to $4.99, during its last trading session.
Merge Healthcare Incorporated, declared Summa Health, one of the largest integrated healthcare delivery systems in Ohio, will integrate Merge’s cardiology solutions to support population health initiatives. The solutions will support Summa’s overarching coordinated care aims, in addition to provide better access to images and data to enhance workflows and reporting.
“By partnering with Merge, we are replacing disparate standalone cardiology applications and improving our ability to analyze data to drive process improvement,” said Kellie Nace, system director for clinical imaging and document archive solutions. “Our aim is to have an all-in-one patient view, consolidate workflow for our clinicians, and enable an efficient structured reporting environment for all of our cardiology modalities.”
Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians worldwide. It operates in two segments, Merge Healthcare and Merge DNA.
Finally, Platform Specialty Products Corp (NYSE:PAH), ended its last trade with -2.24% loss, and closed at $25.34.
Platform Specialty Products Corporation, declared the terms of a recommended offer by Platform to acquire all of the issued and outstanding shares of Alent in a cash and stock transaction for about $2.1 billion2. Counting net debt, the total transaction value is about $2.3 billion.
Under the terms of the transaction, for each Alent share, Alent shareholders will receive 503 pence in cash. The transaction values Alent’s entire issued and to be issued share capital at $2,096 million ([Pounds]1,351 million). This represents a premium of about 49% over Alent’s closing price of 337.7 pence per share as of July 10, 2015, about 37% over the three month volume weighted average share price of 368.2 pence, and about 24% over the 52-week high share price of 406.2 pence on March 12, 2015. The transaction will also comprise a partial share alternative under which eligible Alent shareholders can elect to receive Platform common stock in lieu of part or all of the cash consideration to which they would otherwise be entitled under the transaction.
Platform Specialty Products Corporation produces and sells specialty chemical products in the Americas, Asia, and Europe. The company’s Performance Materials segment manufactures and markets plating products that are used to plate holes; final finishes, which are used on printed circuit boards; circuit formation products to promote adhesion and form circuit patterns; oxides that are used in the fabrication of multilayer circuit boards; and pre-treatment and cleaning solutions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
